Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide)
Authors:
- 1 June 1984
- journal article
- research article
- Published by Springer Nature in Investigational New Drugs
- Vol. 2 (2) , 245-252
Abstract
The contamination of autologous marrow with clonogenic tumor cells has been the main argument against ABMT in acute leukemia. In a preclinical study we evaluated an active cyclophosphamide derivative named “ASTA Z 7557”. We observed that the toxic effect of this drug on CFU-GM growth was dependent on nucleated cell concentration as well as on red blood cell contamination. The potency of the drug was in close relationship with the incubation temperature. The growth of leukemic CFU was inhibited with an ASTA Z dose higher than 30 μg/ml. In our system, beyond 40 μg/ml more than 95% of committed stem cells are destroyed. Fifteen patients had autotransplant because of AML for 10 patients and because of ALL for 5 patients (4 patients were grafted in relapse and 11 patients in remission). We demonstrated that the marrow take was possible although the inoculum is CFU-GM depleted. Five of the 10 AML patients are alive and remain disease-free at 45 +, 65 +, 190 +, 345+ and 570 + days from ABMT without any maintenance treatment. Four of the 5 ALL patients are alive, three of them in complete remission (404+, 110+, 250+ days). The number of patients reported in this clinical study was relatively small and more cases should be evaluated to be conclusive. Nevertheless the feasibility of chemopurified ABMT was demonstrated.Keywords
This publication has 10 references indexed in Scilit:
- Méthode de concentration des cellules-souches médullaires utilisant le laveur IBM 2991: Préalable essentiel avant traitement in vitro de la moelle osseuse par des moyens pharmacologiques ou immunologiquesRevue Française de Transfusion et Immuno-hématologie, 1983
- AUTOLOGOUS STEM CELL GRAFTING IN ACUTE MYELOID LEUKAEMIA: TECHNICAL APPROACH OF MARROW INCUBATION IN VITRO WITH PHARMACOLOGICAL AGENTS (PREREQUISITE FOR CLINICAL APPLICATIONS)British Journal of Haematology, 1983
- High-dose melphalan and autologous bone marrow transplant for relapsed acute leukaemiaCancer Chemotherapy and Pharmacology, 1983
- 4‐Hydroperoxyclophosphamide: a model for eliminating residual human tumour cells and T‐lymphocytes from the bone marrow graftBritish Journal of Haematology, 1982
- Long-term culture of human bone marrow cells.Proceedings of the National Academy of Sciences, 1980
- Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamideBlood, 1980
- AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIAThe Lancet, 1979
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Cyclophosphamide metabolites and their related compounds. II. Preparation of an active species of cyclophosphamide and some related compoundsJournal of the American Chemical Society, 1973
- Colony Formation by Normal and Leukemic Human Marrow Cells in Culture: Effect of Conditioned Medium From Human LeukocytesBlood, 1971